At week 24 , adjusted mean ( SE ) changes from baseline in HbA1c with empagliflozin 25 mg/linagliptin 5 mg , empagliflozin 10 mg/linagliptin 5 mg , empagliflozin 25 mg , empagliflozin 10 mg , and linagliptin 5 mg were -1.08 ( 0.06 ) % ( -11.8 [ 0.7 ] mmol/mol ) , -1.24 ( 0.06 ) % ( -13.6 [ 0.7 ] mmol/mol ) , -0.95 ( 0.06 ) % ( -10.4 [ 0.7 ] mmol/mol ) , -0.83 ( 0.06 ) % ( -9.1 [ 0.7 ] mmol/mol ) , and -0.67 ( 0.06 ) % ( -7.3 [ 0.7 ] mmol/mol ) , respectively .